ETM
ELV icon

Euclidean Technologies Management’s Elevance Health ELV Stock Holding History

Euclidean Technologies Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-9,887
Closed -$2.71M – 66
2018
Q3 		$2.71M Hold
9,887
– – 2.39% 2
2018
Q2 		$2.35M Hold
9,887
– – 2.19% 9
2018
Q1 		$2.17M Sell
9,887
-500
-5% -$117K 2.14% 10
2017
Q4 		$2.31M Sell
10,387
-400
-4% -$85.2K 2.28% 6
2017
Q3 		$2.05M Sell
10,787
-1,800
-14% -$343K 1.96% 22
2017
Q2 		$2.37M Sell
12,587
-453
-3% -$81.4K 2.28% 7
2017
Q1 		$2.16M Sell
13,040
-2,300
-15% -$366K 2% 21
2016
Q4 		$2.21M Hold
15,340
– – 2.03% 16
2016
Q3 		$1.92M Buy
15,340
+600
+4% +$77.5K 1.98% 33
2016
Q2 		$1.94M Buy
14,740
+700
+5% +$95.8K 2.07% 25
2016
Q1 		$1.95M Buy
14,040
+500
+4% +$66.8K 1.99% 34
2015
Q4 		$1.89M Buy
+13,540
New +$1.87M 2.03% 23

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Euclidean Technologies Management's ELV Position: Q4 2018 in Review

Euclidean Technologies Management sold out of Elevance Health (ELV) in Q4 2018, closing a stake of 9,887 shares — an estimated $2.71M sold.

Euclidean Technologies Management first reported a position in ELV in Q4 2015 and held it in 12 quarters. The position peaked at $2.71M in Q3 2018. 999 funds tracked by Wall St. Rank hold ELV as of Q4 2018.

  • Euclidean Technologies Management reported no remaining Elevance Health position as of Q4 2018 after selling out during the quarter.
  • Euclidean Technologies Management sold 9,887 Elevance Health shares in Q4 2018, an estimated $2.71M.
  • Euclidean Technologies Management first reported a position in Elevance Health in Q4 2015 and held it in 12 quarters.
  • Euclidean Technologies Management's Elevance Health position peaked at $2.71M in Q3 2018.
  • 999 funds tracked by Wall St. Rank held Elevance Health as of Q4 2018.

Based on Euclidean Technologies Management's 13F filing for Q4 2018, filed 14 Feb 2019.